KeyBanc Reiterates Overweight Rating on Recursion Pharmaceuticals (RXRX )

Go back to KeyBanc Reiterates Overweight Rating on Recursion Pharmaceuticals (RXRX )
(NASDAQ: RXRX) Delayed: 3.23 +0.12 (3.86%)
Previous Close $3.11    52 Week High
Open $3.18    52 Week Low
Day High $3.28    P/E N/A 
Day Low $3.11    EPS
Volume 24,853,725